Literature DB >> 21557042

Guest editorial: Role of monoclonal antibodies for the prevention and treatment of graft-versus-host disease.

Yoshinobu Kanda1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557042     DOI: 10.1007/s12185-011-0866-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

Review 1.  Prophylaxis regimens for GVHD: systematic review and meta-analysis.

Authors:  R Ram; A Gafter-Gvili; M Yeshurun; M Paul; P Raanani; O Shpilberg
Journal:  Bone Marrow Transplant       Date:  2008-11-10       Impact factor: 5.483

2.  Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.

Authors:  K Oshima; M Sato; K Terasako; S Kimura; S Okuda; S Kako; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2009-08-24       Impact factor: 5.483

3.  Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

Authors:  Daniel Wolff; Armin Gerbitz; Francis Ayuk; Alexander Kiani; Gerhard C Hildebrandt; Georgia B Vogelsang; Sharon Elad; Anita Lawitschka; Gerard Socie; Steven Z Pavletic; Ernst Holler; Hildegard Greinix
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-25       Impact factor: 5.742

4.  Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

Authors:  Maria Teresa Van Lint; Giuseppe Milone; Salvatore Leotta; Cornelio Uderzo; Rosanna Scimè; Sandro Dallorso; Anna Locasciulli; Stefano Guidi; Nicola Mordini; Simona Sica; Laura Cudillo; Franca Fagioli; Carmine Selleri; Barbara Bruno; William Arcese; Andrea Bacigalupo
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

5.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

Authors:  R Storb; H J Deeg; J Whitehead; F Appelbaum; P Beatty; W Bensinger; C D Buckner; R Clift; K Doney; V Farewell
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

Review 6.  Management of acute graft-versus-host disease.

Authors:  Andrea Bacigalupo
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

Review 7.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

8.  Individual physician practice variation in hematopoietic cell transplantation.

Authors:  Stephanie J Lee; Steven Joffe; Andrew S Artz; Richard E Champlin; Stella M Davies; Madan Jagasia; Nancy A Kernan; Fausto R Loberiza; Robert J Soiffer; Mary Eapen
Journal:  J Clin Oncol       Date:  2008-03-31       Impact factor: 44.544

9.  Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.

Authors:  Y Kanda; K Izutsu; H Hirai; H Sakamaki; T Iseki; Y Kodera; S Okamoto; H Mitsui; K Iwato; N Hirabayashi; T Furukawa; A Maruta; M Kasai; Y Atsuta; N Hamajima; A Hiraoka; K Kawa
Journal:  Leukemia       Date:  2004-05       Impact factor: 11.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.